Reported Standalone quarterly numbers for Toheal Pharma are:Net Sales at Rs 0.05 crore in December 2020 up 0% from Rs. 0.00 crore in December 2019.
Quarterly Net Loss at Rs. 0.01 crore in December 2020 up 60.09% from Rs. 0.03 crore in December 2019.
EBITDA stands negative at Rs. 0.01 crore in December 2020 up 66.67% from Rs. 0.03 crore in December 2019.
Toheal Pharm shares closed at 2.36 on March 22, 2021 (BSE)
| Toheal Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'20 | Sep'20 | Dec'19 | | Net Sales/Income from operations | 0.05 | 0.04 | -- | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 0.05 | 0.04 | -- | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.01 | 0.01 | 0.00 | | Depreciation | 0.00 | 0.00 | -- | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.06 | 0.01 | 0.03 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.01 | 0.02 | -0.03 | | Other Income | -- | 0.01 | -- | | P/L Before Int., Excpt. Items & Tax | -0.01 | 0.03 | -0.03 | | Interest | -- | -- | -- | | P/L Before Exceptional Items & Tax | -0.01 | 0.03 | -0.03 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -0.01 | 0.03 | -0.03 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -0.01 | 0.03 | -0.03 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.01 | 0.03 | -0.03 | | Equity Share Capital | 9.48 | 9.48 | 9.48 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.01 | 0.03 | -0.03 | | Diluted EPS | -0.01 | 0.03 | -0.03 | | EPS After Extra Ordinary | | Basic EPS | -0.01 | 0.03 | -0.03 | | Diluted EPS | -0.01 | 0.03 | -0.03 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|